Shire PLC (SHP) Stock Rating Reaffirmed by BNP Paribas


's stock had its "outperform" rating reaffirmed by equities researchers at BNP Paribas in a report released on Wednesday, AnalystRatingsNetwork.com reports. They currently have a GBX 5,700 target price on the biopharmaceutical company's stock.



from Biotech News